
Posted: September 2026
PT-141 (bremelanotide) is a synthetic melanocortin receptor agonist studied for its receptor-selectivity profile, which differs from broader-spectrum melanocortin agonists such as Melanotan-2. Its more targeted receptor-binding characteristics have made it a frequently requested reference compound in central melanocortin-pathway research.
This overview is intended for educational and research information purposes only.
Laboratory interest in PT-141 centers on its receptor-selectivity characteristics and its role as a comparative reference in melanocortin-pathway research models.
Researchers frequently examine:
Its more targeted receptor profile makes it a frequently cited reference when researchers study receptor-selective melanocortin signaling.
Research environments frequently examine how receptor-selective melanocortin agonists behave differently from non-selective agonists in laboratory models.
Research interest frequently includes:
Researchers frequently compare PT-141 with Melanotan-2, a non-selective melanocortin agonist, to evaluate:
Consistent handling procedures support research reproducibility:
PT-141 is supplied for laboratory research applications and educational research purposes only.
No. Research materials supplied by Priority Aminos are not intended for human or veterinary use.
Lot coding supports traceability, documentation, and internal quality procedures.
Comparative analysis may help researchers evaluate differences in receptor selectivity, structural stability, and research-model design.
Consistent storage procedures help maintain documentation standards and improve research consistency.
Research Use Only (RUO). Not for human or veterinary use.
Join our research newsletter for early access to new compounds and COA updates. We'll send a one-time 10% discount code to your inbox.
Research use only (RUO). No spam — unsubscribe anytime.